High-Sensitivity C-Reactive Protein and Statin Initiation

The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular events lack commonly established risk factors. The utility of high-sensitivity C-reactive protein (hsCRP), a circulating biomarker related to inflammation, may provide additional information in risk prediction. This review will consider the impact of hsCRP level on initiation of statin therapy.

Source: Angiology - June 15, 2015 Category: Cardiology Authors: Trpkovic, A., Stanimirovic, J., Rizzo, M., Resanovic, I., Soskic, S., Jevremovic, D., Isenovic, E. R. Tags: Reviews Source Type: research